Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alina M Allen

Showing results (31-40 of 116) with videos related to

Pageof 12
Sort By:
Nature Reviews. Gastroenterology & Hepatology|June 4, 2024
Envisioning how to advance the MASH fieldAlina M Allen, Zobair M Younossi, Anna Mae Diehl, et al.
Gastroenterology|September 28, 2021
AGA Technical Review on Coagulation in CirrhosisNicolas M Intagliata, Perica Davitkov, Alina M Allen, et al.
Journal of Hepatology|August 31, 2019
The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort studyAlina M Allen, Stephen B Hicks, Kristin C Mara, et al.
Gut|October 28, 2023
Beyond a liver-gut focus: the evolution of gastroenterology and hepatology in challenging the obesity and steatotic liver disease paradigmPaul N Brennan, Shira Zelber-Sagi, Alina M Allen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 10, 2021
Longitudinal Changes in MR Elastography-based Biomarkers in Obese Patients Treated with Bariatric SurgeryJiahui Li, Alina M Allen, Vijay H Shah, et al.
Transplantation|July 12, 2018
Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver TransplantationPraveena Narayanan, Kristin Mara, Manhal Izzy, et al.
Clinical and Molecular Hepatology|December 8, 2025
Optimized MASH Treatment Eligibility Cutoffs for MRE-measured Liver Stiffness and Proton Density Fat FractionNana Owusu, Kyle Kalutkiewicz, Jiahui Li, et al.
Hepatology (Baltimore, Md.)|May 19, 2018
Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real-World Data From a Large U.S. Claims DatabaseAlina M Allen, Holly K Van Houten, Lindsey R Sangaralingham, et al.
Hepatology (Baltimore, Md.)|September 12, 2021
Magnetic resonance elastography for prediction of long-term progression and outcome in chronic liver disease: A retrospective studyTolga Gidener, Meng Yin, Ross A Dierkhising, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 15, 2021
Natural History of Nonalcoholic Fatty Liver Disease With Normal Body Mass Index: A Population-Based StudyOmar T Ahmed, Tolga Gidener, Kristin C Mara, et al.
Pageof 12

Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Nature Reviews. Gastroenterology & Hepatology|June 4, 2024
Envisioning how to advance the MASH fieldAlina M Allen, Zobair M Younossi, Anna Mae Diehl, et al.
Gastroenterology|September 28, 2021
AGA Technical Review on Coagulation in CirrhosisNicolas M Intagliata, Perica Davitkov, Alina M Allen, et al.
Journal of Hepatology|August 31, 2019
The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort studyAlina M Allen, Stephen B Hicks, Kristin C Mara, et al.
Gut|October 28, 2023
Beyond a liver-gut focus: the evolution of gastroenterology and hepatology in challenging the obesity and steatotic liver disease paradigmPaul N Brennan, Shira Zelber-Sagi, Alina M Allen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 10, 2021
Longitudinal Changes in MR Elastography-based Biomarkers in Obese Patients Treated with Bariatric SurgeryJiahui Li, Alina M Allen, Vijay H Shah, et al.
Transplantation|July 12, 2018
Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver TransplantationPraveena Narayanan, Kristin Mara, Manhal Izzy, et al.
Clinical and Molecular Hepatology|December 8, 2025
Optimized MASH Treatment Eligibility Cutoffs for MRE-measured Liver Stiffness and Proton Density Fat FractionNana Owusu, Kyle Kalutkiewicz, Jiahui Li, et al.
Hepatology (Baltimore, Md.)|May 19, 2018
Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real-World Data From a Large U.S. Claims DatabaseAlina M Allen, Holly K Van Houten, Lindsey R Sangaralingham, et al.
Hepatology (Baltimore, Md.)|September 12, 2021
Magnetic resonance elastography for prediction of long-term progression and outcome in chronic liver disease: A retrospective studyTolga Gidener, Meng Yin, Ross A Dierkhising, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 15, 2021
Natural History of Nonalcoholic Fatty Liver Disease With Normal Body Mass Index: A Population-Based StudyOmar T Ahmed, Tolga Gidener, Kristin C Mara, et al.
Pageof 12